Campath-1H + FK506 and Methylprednisolone for GVHD
Conditions
- Breast Cancer
- Chronic Myeloproliferative Disorders
- Gestational Trophoblastic Tumor
- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases
- Neuroblastoma
- Ovarian Cancer
- Testicular Germ Cell Tumor
Interventions
- BIOLOGICAL: alemtuzumab
- DRUG: methylprednisolone
- DRUG: tacrolimus
Sponsor
Case Comprehensive Cancer Center
Collaborators